OHSS may cause serious and dangerous issues such as fluid build up in the abdomen and chest
Individuals with a BMI of 30 or higher, or those with a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, hypertension, or high cholesterol, are suitable candidates for GLP injections
This guide walks through how these drugs work, which patients benefit, what the trial data actually show, what to expect in terms of side effects and cost, and the difficult question of what happens when you stop
The SELECT trial actually demonstrated approximately 20% reduction in major cardiovascular events in patients with established heart disease and obesity
doi:10.1089/acm.2010.0716 Rachel Erwin, Nutritionist & Content Writer Rachel is a Nutritionist with a BSc in Biology and Global Health from the University of Toronto, and a Postgraduate Diploma in Human Nutrition from the University of Ulster